Prime-Time Research

For 25 years, IWU\u27s John Wesley Powell Student Research Conference has served as an academic rite of passage, condensing hundreds of hours of scholarly and creative exploration into one climactic moment

Prime Time (for the Basing Relation)

It is often assumed that believing that p for a normative reason consists in nothing more than (i) believing that p for a reason and (ii) that reason’s corresponding to a normative reason to believe that p, where (i) and (ii) are independent factors. This is the Composite View. In this paper, we argue against the Composite View on extensional and theoretical grounds. We advocate an alternative that we call the Prime View. On this view, believing for a normative reason is a distinctive achievement that isn’t exhausted by the mere conjunction of (i) and (ii). Its being an achievement entails that (i) and (ii) are not independent when one believes for a normative reason: minimally, (i) must hold because (ii) holds. Apart from its intrinsic interest, our discussion has important upshots for central issues in epistemology, including the analysis of doxastic justification, the epistemology of perception, and the place of competence in epistemology

Prime TIme

What is a PRIME WORD? There are at least three possible answers to this question

On India's prime time TV debates, women are mostly invisible

The under-representation of expert women in the media is a global trend with women more likely to be invited onto television debates to discuss gender and sexual violence than science and technology. However, lessons can be learned from the UK according to Reshma Patil

Histology driven systemic therapy of liposarcoma-ready for prime time?

Liposarcomas are a subtype of soft tissue sarcomas arising from adipocytes. These mesenchymal tumors have been sub classified into well differentiated liposarcoma (WDLPS), dedifferentiated liposarcoma (DDLPS), myxoid liposarcoma (MLPS) and pleomorphic liposarcoma (PLPS). This article reviews what has been reported regarding the responsiveness of these sarcoma subtypes to traditional and newly developed systemic therapies. The evolution of molecular targets for therapeutic intervention within the distinct histologies is discussed, along with, available evidence regarding the efficacy of novel target directed therapies. Response rates and outcomes for advanced disease therapeutic trials comprises the majority of this information, and where available, data from adjuvant therapy trials is reviewed. Overall survival for patients with advanced liposarcoma treated with systemic therapy is 16.3 months. The article addresses our progress toward the goal of improved liposarcoma outcomes through tailored interventions

Adherence of Prime-Time Television Advertising Disclosures to the “Clear and Conspicuous Standard: 1990 vs. 2002

In 1990, one-fourth of all national television commercials contained disclosures, yet none of the disclosures adhered to all of the Federal Trade Commission\u27s clear and conspicuous standard (CCS). As a result of marketplace changes and a 2001 Federal Trade Commission and National Advertising Division joint workshop, the authors anticipate an increase in the number of disclosures and greater adherence to the CCS. The authors find a significant increase in disclosure incidence; however, adherence declines or remains unchanged for most individual guidelines. Finally, the authors provide public policy implications and offer suggestions to increase adherence to the CCS